MassMutual Private Wealth & Trust’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-9	Closed	-$2.85K	–	2146
2023 Q4	$2.85K	Sell	9 -5	-36%	-$972	﹤0.01%	1399
2023 Q3	$2.37K	Buy	14 +5	+56%	+$940	﹤0.01%	1457
2023 Q2	$1.95K	Buy	9 +3	+50%	+$643	﹤0.01%	1475
2023 Q1	$1.09K	Hold	6	–	–	﹤0.01%	1561
2022 Q4	$1K	Buy	6 +1	+20%	+$214	﹤0.01%	1607
2022 Q3	$1K	Hold	5	–	–	﹤0.01%	1589
2022 Q2	$1K	Hold	5	–	–	﹤0.01%	1468
2022 Q1	$1K	Buy	+5	New	+$563	﹤0.01%	1471

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

MassMutual Private Wealth & Trust's KRTX Position: Q1 2024 in Review

MassMutual Private Wealth & Trust sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 9 shares — an estimated $2.85K sold.

MassMutual Private Wealth & Trust first reported a position in KRTX in Q1 2022 and held it in 8 quarters. The position peaked at $2.85K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

MassMutual Private Wealth & Trust reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
MassMutual Private Wealth & Trust sold 9 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $2.85K.
MassMutual Private Wealth & Trust first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2022 and held it in 8 quarters.
MassMutual Private Wealth & Trust's Karuna Therapeutics, Inc. Common Stock position peaked at $2.85K in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on MassMutual Private Wealth & Trust's 13F filing for Q1 2024, filed 9 Apr 2024.